Australia:PIQ

New Clinical Advisory Board to support PromarkerD global rollout

* Proteomics International establishes world class Clinical Advisory Board promarkerd.com/clinical-advisory-board * Comprises highly-respected physicians specialising in diabetes and kidney disease care fromthe United States, Europe and Austra...

2022-04-12 16:04 1019

PromarkerD distribution network expands to Britain

* World's first predictive diagnostic test for diabetic kidney disease to be sold inGreat Britain under distribution deal with global diagnostic distributor, Apacor Limited * Apacor will become the exclusive distributor for PromarkerD in Great Britain (England, Scotland and Wales) * Estimat...

2021-11-23 11:56 1874

PromarkerD significantly outperforms current standard of care tests in predicting future kidney function decline

* Study shows PromarkerD is significantly better than current standard of care tests eGFR and ACR for predicting future decline in kidney function in patients with type 2 diabetes * PromarkerD correctly identified 84% of patients with normal kidney function that went on to experience kidney f...

2021-11-05 20:37 1758

Diabetes treatment lowers PromarkerD risk score for diabetic kidney disease

BRISBANE, Australia, Aug. 12, 2021 /PRNewswire/ -- Treatment with diabetes drug canagliflozin lowers the PromarkerD risk score for developing diabetic kidney disease in patients with type 2 diabetes, latest research suggests. In a study presented at the Australasian Diabetes Congress today, resea...

2021-08-12 21:30 2268

World-first predictive test for Diabetic Kidney Disease could save $384 billion over 10 years

* Independent modelling estimates the PromarkerD predictive test for diabetic kidney disease (DKD) would increase the quality of care and could save US payers almostUSD400 billion over 10 years * The US is home to 31 million adults with diabetes who are at risk of DKD - cost savings stem from...

2021-06-25 23:30 2738

Proteomics International at American Diabetes Association 78th Scientific Sessions following new license deals for diabetic kidney disease predictive test in USA and Mexico

Medical technology company Proteomics International Laboratories Ltd (Proteomics International; ASX: PIQ) has just signed license agreements for its world-leading PromarkerD predictive test for diabetic kidney disease withUSA and Mexico partners. NEW YORK, June 22, 2018 /PRNewswire/ -- PromarkerD...

2018-06-22 21:00 1696